erythromycin has been researched along with Severe Combined Immunodeficiency in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abe, S; Azuma, A; Enomoto, T; Furuwaka, H; Inoue, T; Juji, T; Keicho, N; Kudo, S; Miyamoto, H; Shinhara, R; Takahashi, T; Usuki, J; Yabe, T; Yamamoto, K | 1 |
| Azuma, A; Furukawa, H; Keicho, N; Kudoh, S; Yabe, T | 1 |
2 other study(ies) available for erythromycin and Severe Combined Immunodeficiency
| Article | Year |
|---|---|
[Case of the bare lymphocyte syndrome successfully treated with long-term small dosage administration of erythromycin].
Topics: Anti-Bacterial Agents; Bronchiolitis; Erythromycin; Female; Histocompatibility Antigens Class I; Humans; Killer Cells, Natural; Middle Aged; Severe Combined Immunodeficiency; Treatment Outcome | 2001 |
Prolonged survival of a bare lymphocyte syndrome type I patient with diffuse panbronchiolitis treated with erythromycin.
Topics: Adult; Anti-Bacterial Agents; Bronchiolitis; Erythromycin; Female; Histocompatibility Antigens Class I; Humans; Severe Combined Immunodeficiency; Survivors; Treatment Outcome | 2001 |